Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marc Monte"'
Autor:
Andrzej Badzio, Sharon Wilks, Hui Yu, Fred R. Hirsch, Jacek Jassem, Donald A. Richards, Brian Ulrich, Kim Ellison, Maen A. Hussein, Jerome Goldschmidt, Caicun Zhou, Dexiang Gao, Xian Lu, Marc Monte, Daniel C. Chan, Sandra Close, Christopher J. Rivard, Ashley Kowalewski, Ray D. Page, William Jeffery Edenfield, Cory Batenchuk, Kimary Kulig, Piotr Czapiewski, Theresa A. Boyle, Rafal Dziadziuszko, David M. Waterhouse
Publikováno v:
Journal of Thoracic Oncology. 12:110-120
Therapeutic antibodies to immune checkpoints show promising results. Programmed death-ligand 1 (PD-L1), an immune checkpoint ligand, blocks the cancer immunity cycle by binding the PD-L1 receptor (programmed death 1). We investigated PD-L1 protein ex
Autor:
Stephanie A. Gregory, Marc Monte, Robert C. Hermann, Akiko Chai, Kevin S. Windsor, Paul Richards, Michael Brewster, Shaker R. Dakhil, Marshall T. Schreeder, Deborah Hurst
Publikováno v:
Leukemia & Lymphoma. 55:2335-2340
This phase III, multicenter, single-arm trial investigated the impact of 90 min rituximab infusions on infusion-related reactions (IRRs) in patients with untreated diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL). Patients received s
Autor:
Jenine Sanzari, Mark D. Danese, Beata Korytowsky, Yong Yuan, Steven L. McCune, Bijoy PanKaj Telivala, Deborah P. Lubeck, Lee S. Schwartzberg, Maen A. Hussein, Pranav Abraham, John R. Penrod, Brian Ulrich, Donald A. Richards, Marc Monte, Michelle Gleeson
Publikováno v:
Journal of Clinical Oncology. 36:e20567-e20567
e20567Background: Limited 2L therapy options and no established 3L standard of care make treating relapsed ED-SCLC challenging. This study explores current treatment and outcomes in patients receiv...
Autor:
Thomas Anderson, Brian Ulrich, Mahesh Seetharam, Ray D. Page, Cory Batenchuk, Paul Kaywin, Si G Li, Donald A. Richards, David Smith, Maen A. Hussein, Marc Monte, Kimary Kulig
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts The majority of lung cancer in the U.S. is treated in the community. A prospective cohort study of stage IV NSCLC and extensive disease (ED) SCLC is being conducted in 70 U.S. community practices to assess outcomes during the pre- a
Autor:
Lisu Wang, Zhenhao Qi, Saumya Pant, Donald A. Richards, Jason D. Hipp, Kimary Kulig, Kaushal Desai, Sharon Wilks, David M. Waterhouse, Harlan Robins, Jerome H. Goldschmidt, Darin Taverna, Erik Yusko, Ryan O. Emerson, Marc Monte, Cory Batenchuk, Maen A. Hussein, Spyro Mousses
Publikováno v:
Cancer Research. 76:4159-4159
Background: The current study explores T-cell (TC) clonality and molecular factors associated with this metric. Tumors employ multiple mechanisms to evade antitumor immune responses. One process involves TC inhibition via upregulation of immune check
Publikováno v:
IET Radar, Sonar & Navigation, Vol 15, Iss 8, Pp 867-883 (2021)
Abstract The problem of radar helicopter detection and classification requires simple and fast modelling of rotorcraft signature to aid the design of specific waveforms or to provide quality training data to machine learning algorithms. Here, we pres
Externí odkaz:
https://doaj.org/article/e9acfd9004ee4317ae1a3c50bdd2a8ce
Publikováno v:
American Journal of Hematology. 43:86-90
We observed increased hemoglobin A2 (HbA2) levels in an asymptomatic human immunodeficiency virus-1 (HIV1) patient with no previous history of beta-thalassemia. He was treated only with zidovudine (AZT). In an attempt to understand this observation,
Autor:
Andre Lorange, Jean A. Neemeh, Christophe Louvet, Marc Monte, Jean Latreille, Harry M. Pretty, Francois Letendre, Raymond Beaulieu, Yves Courchesne
Publikováno v:
Oncology. 48:392-396
Lorazepam, dexamethasone and high-dose metoclopramide were given to 54 patients to prevent emesis induced by cisplatin (50-120 mg/m2) on day 1, while prochlorperazine and dexamethasone were administered on days 2 and 3 for control of delayed emesis.
Publikováno v:
American journal of hematology. 38(4)
Two homosexual HIV1-positive male patients with thrombotic thrombopenic purpura (TTP) were found to have past history of immune thrombocytopenia (ITP). The first patient had ITP 10 months prior to TTP and was successfully treated by splenectomy. The
Autor:
Alan G. Harris, Marc Monte, Gerard F. Murphy, Mary Broadhead, Mary Fanning, Lloyd R. Sutherland
Publikováno v:
Digestive diseases and sciences. 36(4)
Seventeen AIDS patients were enrolled in a prospective open-label dose-finding study of octreotide (Sandostatin) therapy for refractory diarrhea. Five were nonevaluable due to progression of AIDS symptomatology, and one was excluded because of lack o